PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi\'an, China. hjbian@fmmu.edu.cn.\', \'Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\'an, China.\', \'National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi\'an, China.\', \'Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi\'an, China.\', \'Center for Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi\'an, China.\', \'Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi\'an, China.\', \'Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi\'an, China.\', \'College of Military Preventive Medicine, Fourth Military Medical University, Xi\'an, China.\', \'Department of Pharmaceutics, Tangdu Hospital, Fourth Military Medical University, Xi\'an, China.\', \'Department of Pathology, Fourth Military Medical University, Xi\'an, China.\', \'Jiangsu Pacific Meinuoke Biopharmaceutical Co. Ltd, Changzhou, China.\', \'Department of Foreign Languages, Fourth Military Medical University, Xi\'an, China.\', \'National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi\'an, China. znchen@fmmu.edu.cn.\', \'Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\'an, China. zhuping@fmmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41392-021-00603-6
?:doi
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 34001849
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34001849>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34001849>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all